Targeting and Microenvironment-Activated Nanoreactor for Diabetic Chronic Wound Healing via Multienzyme Cascade Reactions.
Ge LiYibing HuangLin-Lu ZhaoBo YangJiale GuoJuntao HuJinli WangHui WangBin LiuAiguo ZhangFengying SunQuan LuoPublished in: ACS applied materials & interfaces (2024)
The development of cell-like nanoreactors with the ability to initiate biocatalytic cascades under special conditions holds tremendous potential for therapeutic applications. Herein, conformationally gated nanoreactors that respond to the acidic microenvironment of infected diabetic wounds were developed by cucur[8]bituril (CB[8])-based supramolecular assembly. The bioinspired nanoreactors exhibit not only self-regulated permeability and selectivity to control internal enzyme activities by substance exchange but also distinct binding specificities toward Gram-positive and Gram-negative bacteria via noncovalent modification with different ligands. The encapsulation of glucose oxidase (GOx), Fe 3 O 4 nanozyme, and l-arginine (l-Arg) into the nanocarriers enables intelligent activation of multienzyme cascade reactions upon glucose (Glu) uptake to produce gluconic acid (GA) and hydrogen peroxide (H 2 O 2 ), which is further converted into highly toxic hydroxyl radicals (·OH) for selective antibacterial activity. Moreover, acidic H 2 O 2 promotes the oxidization of l-Arg, leading to the release of nitric oxide (NO). Consequently, this nanoreactor provides a multifunctional and synergistic platform for diabetic chronic wound healing by combining enzyme dynamic therapy with NO gas therapy to combat bacterial infections and inflammation under high blood Glu levels.
Keyphrases
- wound healing
- hydrogen peroxide
- nitric oxide
- cancer therapy
- drug delivery
- stem cells
- nitric oxide synthase
- ionic liquid
- cell therapy
- type diabetes
- transcription factor
- blood glucose
- high throughput
- room temperature
- endothelial cells
- skeletal muscle
- gram negative
- drug induced
- weight loss
- silver nanoparticles
- blood pressure
- multidrug resistant
- binding protein
- bone marrow
- structural basis